QAN:ASXQantas Airways Limited Analysis
Data as of 2026-06-12 - not real-time
A$9.37
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Qantas Airways (QAN) trades at AUD 9.37, comfortably above its short‑term support of AUD 8.40 and the 20‑day SMA of AUD 9.03, while still below the 50‑day SMA of AUD 8.87, indicating a modest technical cushion. Momentum indicators are cautiously bullish – the RSI sits at 59 and the MACD histogram is positive, supporting a near‑term upside bias. However, the 30‑day volatility of 33% and a beta of 0.71 suggest the stock can swing sharply despite its lower market‑risk profile. Fundamentally, the company appears significantly undervalued: a trailing PE of 8.84 versus an industry average of 30.4, a dividend yield of 4.4% with a modest 31% payout ratio, and a DCF‑derived fair value of AUD 26.85 imply upside potential well beyond the modest 18% upside/downside metric. The balance sheet is leveraged, with total debt of AUD 8.24 bn against cash of AUD 1.86 bn, yielding a high debt‑to‑equity of 610%, which tempers the attractiveness of the dividend and price appreciation. Operating cash flow remains positive at AUD 3.93 bn, but free cash flow is negative, indicating capital‑intensive operations. Overall, the stock offers a blend of value and modest growth, underpinned by a strong brand and diversified revenue streams across domestic, international, and low‑cost Jetstar operations.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above short‑term support and SMA20
- Bullish MACD and RSI in neutral range
- Stable trading volume supporting liquidity
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap versus DCF fair value
- Attractive dividend yield with low payout ratio
- Revenue growth of ~6% and solid operating cash flow
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term undervaluation relative to industry PE
- Brand strength and diversified airline segments
- Potential for debt reduction as cash flow improves
Key Metrics & Analysis
Financial Health
Revenue Growth6.30%
Profit Margin6.53%
P/E Ratio8.8
ROE153.63%
ROA6.90%
Debt/Equity610.90
P/B Ratio10.6
Op. Cash FlowA$3.9B
Free Cash FlowA$-603500032
Industry P/E30.4
Technical Analysis
TrendNeutral
RSI59.0
SupportA$8.40
ResistanceA$9.53
MA 20A$9.03
MA 50A$8.87
MA 200A$9.87
MACDBullish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair ValueA$26.85
Target PriceA$11.07
Upside/Downside18.16%
GradeUndervalued
TypeBlend
Dividend Yield4.40%
Risk Assessment
Beta0.71
Volatility33.17%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.